Riitta Lahesmaa
5Patents
1h-index
12Co-inventors
44Inventor score
Filing activity: Mar 17, 2004 → Nov 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7659077B2 | Methods utilizing target genes related to immune-mediated diseases | Physics | 1 | Expired |
| US8143029B2 | Methods and means related to diseases | Chemistry; Metallurgy | 0 | Active |
| US7989172B2 | Method of identifying a compound capable of modulating the Th2 polarization of CD4+ lymphocytes | Chemistry; Metallurgy | 0 | Active |
| US12007391B2 | Means and methods for determining risk of type-1 diabetes by serum protein biomarkers | Physics | 0 | Active |
| US10877034B2 | Means and methods for determining risk of type-1 diabetes by serum protein biomarkers | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.